Not logged in.png)
Share.png)
SaveShare Save Share Save Comparison of AI-Based Morphological Biomarker Score, Pathologists' Prediction Index and PD-L1 IHC in Predicting ICI Response Using the LC-SCRUM-IBIS Cohort; Advantages and Challenges of AI Usage
Motoi, Noriko; Kiyuna, Tomoharu; Ishii, Genichiro; Taki, Tetsuro; Amori, Gulanbar; Nagata, Marino; Murakami, Chiaki; Yoh, Kiyotaka; Kanda, Hiroaki Share Save Neutrophil-to-lymphocyte ratio is a prognostic factor reflecting immune condition of tumor microenvironment in squamous cell lung cancer (vol 14, 429, 2024)Ohashi, Kana; Nishito, Yukari; Fukuda, Hironori; Sadahiro, Ryoichi; Yoshida, Yukihiro; Watanabe, Shun-ichi; Motoi, Noriko; Sonobe, Yukiko; Mizuno, Hideaki; Tsunoda, Hiroyuki; Tatsumi, Koichiro; Suzuki, Takuji; Ochiai, Atsushi; Aoki, Kazunori Share Save Survival Impacts of Mitochondrial Status in Esophageal Squamous Cell Carcinoma PatientsSugawara, Kotaro; Sakashita, Shingo; Fukuda, Takashi; Murakami, Chiaki; Oka, Daiji; Amori, Gulanbar; Ishibashi, Kumiko; Kobayashi, Yasuhito; Kanda, Hiroaki; Motoi, Noriko Share Save Share Save Evaluating Cellularity Estimation Methods: Comparing AI Counting with Pathologists' Visual EstimatesKiyuna, Tomoharu; Cosatto, Eric; Hatanaka, Kanako C.; Yokose, Tomoyuki; Tsuta, Koji; Motoi, Noriko; Makita, Keishi; Shimizu, Ai; Shinohara, Toshiya; Suzuki, Akira; Takakuwa, Emi; Takakuwa, Yasunari; Tsuji, Takahiro; Tsujiwaki, Mitsuhiro; Yanai, Mitsuru; Yuzawa, Sayaka; Ogura, Maki; Hatanaka, Yutaka Share Save Whole-genome sequencing reveals the molecular implications of the stepwise progression of lung adenocarcinomaHaga, Yasuhiko; Sakamoto, Yoshitaka; Kajiya, Keiko; Kawai, Hitomi; Oka, Miho; Motoi, Noriko; Shirasawa, Masayuki; Yotsukura, Masaya; Watanabe, Shun-Ichi; Arai, Miyuki; Zenkoh, Junko; Shiraishi, Kouya; Seki, Masahide; Kanai, Akinori; Shiraishi, Yuichi; Yatabe, Yasushi; Matsubara, Daisuke; Suzuki, Yutaka; Noguchi, Masayuki; Kohno, Takashi; Suzuki, Ayako Share Save Tumor microenvironment-mediated immune profiles and efficacy of anti-PD-L1 antibody plus chemotherapy stratified by DLL3 expression in small-cell lung cancer (vol 129, 2034, 2023)Shirasawa, Masayuki; Yoshida, Tatsuya; Shiraishi, Kouya; Goto, Naoko; Yagishita, Shigehiro; Imabayashi, Tatsuya; Matsumoto, Yuji; Masuda, Ken; Shinno, Yuki; Okuma, Yusuke; Goto, Yasushi; Horinouchi, Hidehito; Yotsukura, Masaya; Yoshida, Yukihiro; Nakagawa, Kazuo; Naoki, Katsuhiko; Tsuchida, Takaaki; Hamamoto, Ryuji; Yamamoto, Noboru; Motoi, Noriko; Kohno, Takashi; Watanabe, Shun-ichi; Ohe, Yuichiro Share Save Impact of tumor genomic alterations on development of cancer cachexia in patients with advanced non-small cell lung cancerFujii, Hiroyuki; Yoshida, Tatsuya; Shirasawa, Masayuki; Fujimoto, Kazushi; Mizuno, Takaaki; Sunami, Kuniko; Koyama, Takafumi; Motoi, Noriko; Shinno, Yuki; Okuma, Yusuke; Goto, Yasushi; Horinouchi, Hidehito; Yamamoto, Noboru; Ohe, Yuichiro Share Save Tumor microenvironment-mediated immune profiles and efficacy of anti-PD-L1 antibody plus chemotherapy stratified by DLL3 expression in small-cell lung cancerShirasawa, Masayuki; Yoshida, Tatsuya; Shiraishi, Kouya; Goto, Naoko; Yagishita, Shigehiro; Imabayashi, Tatsuya; Matsumoto, Yuji; Masuda, Ken; Shinno, Yuki; Okuma, Yusuke; Goto, Yasushi; Horinouchi, Hidehito; Yotsukura, Masaya; Yoshida, Yukihiro; Nakagawa, Kazuo; Naoki, Katsuhiko; Tsuchida, Takaaki; Hamamoto, Ryuji; Yamamoto, Noboru; Motoi, Noriko; Kohno, Takashi; Watanabe, Shun-ichi; Ohe, Yuichiro Share Save Clinical Characteristics and Pharmacokinetics Change of Long-Term Responders to Antiprogrammed Cell Death Protein 1 Inhibitor Among Patients With Advanced NSCLCJo, Hitomi; Yoshida, Tatsuya; Yagishita, Shigehiro; Ohuchi, Mayu; Matsumoto, Yuji; Shinno, Yuki; Okuma, Yusuke; Goto, Yasushi; Horinouchi, Hidehito; Yamamoto, Noboru; Takahashi, Kazuhisa; Motoi, Noriko; Hamada, Akinobu; Ohe, Yuichiro Share Save Guidelines for Handling of Cytological Specimens in Cancer Genomic MedicineMorii, Eiichi; Hatanaka, Yutaka; Motoi, Noriko; Kawahara, Akihiko; Hamakawa, Shinji; Kuwata, Takeshi; Nagatomo, Tadasuke; Oda, Yoshinao; Okamoto, Aikou; Tanaka, Ryota; Iyoda, Akira; Ichiro, Maeda; Matsuo, Yukiko; Nakamura, Nobuyuki; Nakai, Tokiko; Fukuhara, Mei; Tokita, Kazuya; Yamaguchi, Tomohiko; Takenaka, Masataka; Kawabata, Ayako; Hatanaka, Kanako C.; Tsubame, Kaho; Satoh, Yukitoshi Share Save Comprehensive biomarker analysis from phase II study of nivolumab in patients with thymic carcinomaKatsuya, Yuki; Kitano, Shigehisa; Yamashita, Makiko; Ouchi, Mayu; Yagishita, Shigehiro; Hamada, Akinobu; Nakamura, Hiromi; Hosoda, Fumie; Shibata, Tatsuhiro; Motoi, Noriko; Nakayama, Takayuki; Seto, Takashi; Umemura, Shigeki; Hosomi, Yukio; Satouchi, Miyako; Nishio, Makoto; Kozuki, Toshiyuki; Hida, Toyoaki; Ohe, Yuichiro; Horinouchi, Hidehito Share Save Concurrent High PD-L1 Expression and CD8+ Immune Cell Infiltration Predict PD-1 Blockade Efficacy in Advanced EGFR-Mutant NSCLC PatientsShimoda, Yukiko; Shibaki, Ryota; Yoshida, Tatsuya; Murakami, Shuji; Shirasawa, Masayuki; Torasawa, Masahiro; Matsumoto, Yuji; Masuda, Ken; Shinno, Yuki; Okuma, Yusuke; Goto, Yasushi; Horinouchi, Hidehito; Yamamoto, Noboru; Ohe, Yuichiro; Motoi, Noriko Share Save An association between p16/MTAP status and the efficacy of cisplatin-plus-pemetrexed or nivolumab treatment of MPMShinno, Yuki; Shimoda, Yukiko; Masuda, Ken; Matsumoto, Yuji; Okuma, Yusuke; Yoshida, Tatsuya; Goto, Yasushi; Horinouchi, Hidehito; Yamamoto, Noboru; Motoi, Noriko; Yatabe, Yasushi; Ohe, Yuichiro Share Save Comparative Study on the Efficacy and Exposure of Molecular Target Agents in Non-small Cell Lung Cancer PDX Models with Driver Genetic AlterationsJo, Hitomi; Yagishita, Shigehiro; Hayashi, Yoshiharu; Ryu, Shoraku; Suzuki, Mikiko; Kohsaka, Shinji; Ueno, Toshihide; Matsumoto, Yuji; Horinouchi, Hidehito; Ohe, Yuichiro; Watanabe, Shun-ichi; Motoi, Noriko; Yatabe, Yasushi; Mano, Hiroyuki; Takahashi, Kazuhisa; Hamada, Akinobu Share Save Baseline PD-L1 expression and tumour-infiltrated lymphocyte status predict the efficacy of durvalumab consolidation therapy after chemoradiotherapy in unresectable locally advanced patients with non-small-cell lung cancerShirasawa, Masayuki; Yoshida, Tatsuya; Imabayashi, Tatsuya; Okuma, Kae; Matsumoto, Yuji; Masuda, Ken; Shinno, Yuki; Okuma, Yusuke; Goto, Yasushi; Horinouchi, Hidehito; Tsuchida, Takaaki; Yamamoto, Noboru; Nakayama, Yuko; Watanabe, Shun-ichi; Motoi, Noriko; Ohe, Yuichiro Share Save Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
